On Friday, September 30, 2016, the President signed into law:
S.
1878, the “Advancing Hope Act of 2016,” which modifies the Food and
Drug Administration priority review voucher program for rare pediatric
diseases and extends authority
for the program through December 31, 2016.
Source: The White House, Office of the Press Secretary
No comments:
Post a Comment